首页> 外文期刊>Molecular imaging >Different Strategies for Reducing Intestinal Background Radioactivity Associated with Imaging HSV1-tk Expression Using Established Radionucleoside Probes
【24h】

Different Strategies for Reducing Intestinal Background Radioactivity Associated with Imaging HSV1-tk Expression Using Established Radionucleoside Probes

机译:使用已建立的放射性核苷探针降低与成像HSV1-tk表达相关的肠道背景放射性的不同策略

获取原文
获取原文并翻译 | 示例
       

摘要

One limitation of HSV1-tk reporter positron emission tomography (PET) with nucleoside analogues is the high background radioactivity in the intestine. We hypothesized that endogenous expression of thymidine kinase in bacterial flora could phosphorylate and trap such radiotracers, contributing to the high radioactivity levels in the bowel, and therefore explored different strategies to increase fecal elimination of radiotracer. Intestinal radioactivity was assessed by in vivo microPET imaging and ex vivo tissue sampling following intravenous injection of ~(18)F-FEAU, ~(124)I-FIAU, or ~(18)F-FHBG in a germ-free mouse strain. We also explored the use of an osmotic laxative agent and/or a 100% enzymatically hydrolyzed liquid diet. No significant differences in intestinal radioactivity were observed between germ-free and normal mice. ~(18)F-FHBG-derived intestinal radioactivity levels were higher than those of ~(18)F-FEAU and ~(124)I-FIAU; the intestine to blood ratio was more than 20-fold higher for ~(18)F-FHBG than for ~(18)F-FEAU and ~(124)I-FIAU. The combination of Peptamen and Nulytely lowered intestinal radioactivity levels and increased (2.2-fold) the HSV1-tk transduced xenograft to intestine ratio for ~(18)F-FEAU. Intestinal bacteria in germ-free mice do not contribute to the high intestinal levels of radioactivity following injection of radionucleoside analogues. The combination of Peptamen and Nulytely increased radiotracer elimination by increasing bowel motility without inducing dehydration.
机译:HSV1-tk报告基因正电子发射断层显像(PET)具有核苷类似物的局限性是肠道中的高本底放射性。我们假设细菌菌群中胸苷激酶的内源表达可以磷酸化并捕获此类放射性示踪剂,从而促进肠道中高放射性水平,因此我们探索了不同的策略来增加粪便中放射性示踪剂的消除。在无菌小鼠品系中静脉注射〜(18)F-FEAU,〜(124)I-FIAU或〜(18)F-FHBG后,通过体内microPET成像和离体组织采样评估肠道放射性。我们还探讨了渗透性泻药和/或100%酶水解流质饮食的使用。在无菌小鼠和正常小鼠之间,没有观察到肠道放射性的显着差异。 〜(18)F-FHBG衍生的肠道放射性水平高于〜(18)F-FEAU和〜(124)I-FIAU; 〜(18)F-FHBG的肠血比比〜(18)F-FEAU和〜(124)I-FIAU高20倍以上。 Peptamen和Nulytely的组合可降低〜(18)F-FEAU的肠道放射性水平,并增加(2.2倍)HSV1-tk转导的异种移植物与肠的比例。注射放射性核苷类似物后,无菌小鼠中的肠道细菌不会导致高水平的放射性。 Peptamen和Nulytely的结合通过增加肠蠕动而增加了放射性示踪剂的消除,而不会引起脱水。

著录项

  • 来源
    《Molecular imaging》 |2010年第1期|47-58|共12页
  • 作者单位

    Departments of Radiology, Medical Physics, and Neurology, Cyclotron and Radiochemistry Core Facility, and Research Animal Resource Center, Memorial Sloan-Kettering Cancer Center, New York, NY, and Department of Radiology, Division of Pediatric Radiology, Medical University of Graz, Graz, Austria;

    Departments of Radiology, Medical Physics, and Neurology, Cyclotron and Radiochemistry Core Facility, and Research Animal Resource Center, Memorial Sloan-Kettering Cancer Center, New York, NY, and Department of Radiology, Division of Pediatric Radiology, Medical University of Graz, Graz, Austria;

    Departments of Radiology, Medical Physics, and Neurology, Cyclotron and Radiochemistry Core Facility, and Research Animal Resource Center, Memorial Sloan-Kettering Cancer Center, New York, NY, and Department of Radiology, Division of Pediatric Radiology, Medical University of Graz, Graz, Austria;

    Departments of Radiology, Medical Physics, and Neurology, Cyclotron and Radiochemistry Core Facility, and Research Animal Resource Center, Memorial Sloan-Kettering Cancer Center, New York, NY, and Department of Radiology, Division of Pediatric Radiology, Medical University of Graz, Graz, Austria;

    Departments of Radiology, Medical Physics, and Neurology, Cyclotron and Radiochemistry Core Facility, and Research Animal Resource Center, Memorial Sloan-Kettering Cancer Center, New York, NY, and Department of Radiology, Division of Pediatric Radiology, Medical University of Graz, Graz, Austria;

    Departments of Radiology, Medical Physics, and Neurology, Cyclotron and Radiochemistry Core Facility, and Research Animal Resource Center, Memorial Sloan-Kettering Cancer Center, New York, NY, and Department of Radiology, Division of Pediatric Radiology, Medical University of Graz, Graz, Austria;

    Departments of Radiology, Medical Physics, and Neurology, Cyclotron and Radiochemistry Core Facility, and Research Animal Resource Center, Memorial Sloan-Kettering Cancer Center, New York, NY, and Department of Radiology, Division of Pediatric Radiology, Medical University of Graz, Graz, Austria;

    Departments of Radiology, Medical Physics, and Neurology, Cyclotron and Radiochemistry Core Facility, and Research Animal Resource Center, Memorial Sloan-Kettering Cancer Center, New York, NY, and Department of Radiology, Division of Pediatric Radiology, Medical University of Graz, Graz, Austria Departments of Neurology and Radiology, MH (Box 52), Molecular Pharmacology and Chemistry Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 00:39:15

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号